Exploring mechanisms of diabetes-related macrovascular complications: Role of methylglyoxal, a metabolite of glucose on regulation of vascular contractility

Journal of Pharmacological Sciences

Volumn 118, Issue 3, 2012, Pages 303-310

  Mukohda, Masashi ^a   Okada, Muneyoshi ^a   Hara, Yukio ^a   Yamawaki, Hideyuki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Diabetes; Glucose metabolite; Hypertension; Reactive oxygen species; Vascular reactivity

Indexed keywords

3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; APAMIN; ARGPYRIMIDINE; GLIBENCLAMIDE; GLUCOSE; GLYOXAL; IBERIOTOXIN; INDOMETACIN; LOSARTAN; METHYLGLYOXAL; N(CARBOXYETHYL)LYSINE; REACTIVE OXYGEN METABOLITE; TETRAMETHYLAMMONIUM; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE ACTIVITY; AORTA; APOPTOSIS; ARTERY CONSTRICTION; ARTERY WALL; BIOACCUMULATION; BLOOD LEVEL; BLOOD VESSEL REACTIVITY; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; LONG TERM CARE; MESENTERIC ARTERY; MICROANGIOPATHY; NONHUMAN; PATHOGENESIS; REVIEW; SHORT COURSE THERAPY; SMOOTH MUSCLE CONTRACTILITY; TISSUE DISTRIBUTION; VASODILATATION;

EID: 84859498734     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.11R12CP     Document Type: Review

References (40)

1. Schalkwijk CG, van Bezu J, van der Schors RC, Uchida K, Stehouwer CD, van Hinsbergh VW. Heat-shock protein 27 is a major methylglyoxal-modified protein in endothelial cells. FEBS Lett. 2006;580:1565-1570. (Pubitemid 43290351)
2. Wu L. Is methylglyoxal a causative factor for hypertension development? Can J Physiol Pharmacol. 2006;84:129-139. (Pubitemid 44011957)
3. Desai KM, Chang T, Wang H, Banigesh A, Dhar A, Liu J, et al. Oxidative stress and aging: is methylglyoxal the hidden enemy? Can J Physiol Pharmacol. 2010;88:273-284.
4. Takatsume Y, Izawa S, Inoue Y. Modulation of Spc1 stress-activated protein kinase activity by methylglyoxal through inhibition of protein phosphatase in the fission yeast Schizosaccharomyces pombe. Biochem Biophys Res Commun. 2007;363:942-947. (Pubitemid 47552969)
5. Yim HS, Kang SO, Hah YC, Chock PB, Yim MB. Free radicals generated during the glycation reaction of amino acids by methylglyoxal. A model study of protein-cross-linked free radicals. J Biol Chem. 1995;270:28228-28233.
6. Oya T, Hattori N, Mizuno Y, Miyata S, Maeda S, Osawa T, et al. Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem. 1999;274:18492-18502.
7. Ahmed MU, Brinkmann Frye E, Degenhardt TP, Thorpe SR, Baynes JW. N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J. 1997;324(Pt 2): 565-570.
8. Ahmed N, Thornalley PJ. Chromatographic assay of glycation adducts in human serum albumin glycated in vitro by derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and intrinsic fluorescence. Biochem J. 2002;364:15-24. (Pubitemid 34538941)
9. Wells-Knecht KJ, Brinkmann E, Wells-Knecht MC, Litchfield JE, Ahmed MU, Reddy S, et al. New biomarkers of Maillard reaction damage to proteins. Nephrol Dial Transplant. 1996; 11 Suppl 5:41-47. (Pubitemid 27062910)
10. Vander Jagt DL, Hunsaker LA. Methylglyoxal metabolism and diabetic complications: roles of aldose reductase, glyoxalase-I, betaine aldehyde dehydrogenase and 2-oxoaldehyde dehydrogenase. Chem Biol Interact. 2003;143-144:341-351. (Pubitemid 36253593)
11. Wang H, Liu J, Wu L. Methylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells. Biochem Pharmacol. 2009;77:1709-1716.
12. Cantero AV, Portero-Otin M, Ayala V, Auge N, Sanson M, Elbaz M, et al. Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. FASEB J. 2007;21: 3096-3106. (Pubitemid 47565530)
13. Thornalley PJ, Hooper NI, Jennings PE, Florkowski CM, Jones AF, Lunec J, et al. The human red blood cell glyoxalase system in diabetes mellitus. Diabetes Res Clin Pract. 1989;7:115-120. (Pubitemid 19221706)
14. McLellan AC, Thornalley PJ, Benn J, Sonksen PH. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clin Sci (Lond). 1994;87:21-29. (Pubitemid 24220267)
15. Odani H, Shinzato T, Matsumoto Y, Usami J, Maeda K. Increase in three alpha,beta-dicarbonyl compound levels in human uremic plasma: specific in vivo determination of intermediates in advanced Maillard reaction. Biochem Biophys Res Commun. 1999;256:89-93. (Pubitemid 29298922)
16. Lapolla A, Flamini R, Dalla Vedova A, Senesi A, Reitano R, Fedele D, et al. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clin Chem Lab Med. 2003;41:1166-1173. (Pubitemid 37265695)
17. Wang X, Desai K, Clausen JT, Wu L. Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats. Kidney Int. 2004;66:2315-2321. (Pubitemid 41115295)
18. Wang X, Desai K, Chang T, Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J Hypertens. 2005;23:1565-1573. (Pubitemid 41104829)
19. Mostafa AA, Randell EW, Vasdev SC, Gill VD, Han Y, Gadag V, et al. Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes. Mol Cell Biochem. 2007;302:35-42. (Pubitemid 47202318)
20. Fosmark DS, Torjesen PA, Kilhovd BK, Berg TJ, Sandvik L, Hanssen KF, et al. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Metabolism. 2006;55:232-236. (Pubitemid 43098992)
21. Webster J, Urban C, Berbaum K, Loske C, Alpar A, Gartner U, et al. The carbonyl scavengers aminoguanidine and tenilsetam protect against the neurotoxic effects of methylglyoxal. Neurotox Res. 2005;7:95-101.
22. Taneda S, Honda K, Tomidokoro K, Uto K, Nitta K, Oda H. Eicosapentaenoic acid restores diabetic tubular injury through regulating oxidative stress and mitochondrial apoptosis. Am J Physiol Renal Physiol. 2010;299:F1451-F1461.
23. Munch G, Westcott B, Menini T, Gugliucci A. Advanced glycation endproducts and their pathogenic roles in neurological disorders. Amino Acids. In press.
24. Brouwers O, Niessen PM, Ferreira I, Miyata T, Scheffer PG, Teerlink T, et al. Overexpression of glyoxalase-I reduces hyperglycemia-induced levels of advanced glycation end products and oxidative stress in diabetic rats. J Biol Chem. 2011;286: 1374-1380.
25. Yamawaki H, Saito K, Okada M, Hara Y. Methylglyoxal mediates vascular inflammation via JNK and p38 in human endothelial cells. Am J Physiol Cell Physiol. 2008;295:C1510-C1517.
26. Yamawaki H, Hara Y. Glyoxal causes inflammatory injury in human vascular endothelial cells. Biochem Biophys Res Commun. 2008;369:1155-1159.
27. Rabbani N, Godfrey L, Xue M, Shaheen F, Geoffrion M, Milne R, et al. Glycation of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetes. Diabetes. 2011;60:1973-1980.
28. Vasdev S, Ford CA, Longerich L, Parai S, Gadag V, Wadhawan S. Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine. Artery. 1998;23:10-36. (Pubitemid 30045665)
29. Guo Q, Mori T, Jiang Y, Hu C, Osaki Y, Yoneki Y, et al. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J Hypertens. 2009;27: 1664-1671.
30. Mukohda M, Yamawaki H, Nomura H, Okada M, Hara Y. Methylglyoxal inhibits smooth muscle contraction in isolated blood vessels. J Pharmacol Sci. 2009;109:305-310.
31. Mukohda M, Yamawaki H, Okada M, Hara Y. Methylglyoxal enhances sodium nitroprusside-induced relaxation in rat aorta. J Pharmacol Sci. 2010;112:176-183.
32. Mukohda M, Ueno S, Kamibayashi M, Okada M, Yamawaki H, Hara Y. Influences of organic solvents on CYPMPO-electron spin resonance spectra in in vitro radical generating systems. J Vet Med Sci. 2010;72:1547-1550.
33. Mukohda M, Yamawaki H, Okada M, Hara Y. Methylglyoxal augments angiotensin II-induced contraction in rat isolated carotid artery. J Pharmacol Sci. 2010;114:390-398.
34. Yamawaki H, Sato K, Hori M, Ozaki H, Nakamura S, Nakayama H, et al. Impairment of EDR by a long-term PDGF treatment in organ-cultured rabbit mesenteric artery. Am J Physiol. 1999; 277:H318-H323. (Pubitemid 29354707)
35. Morita T, Yamawaki H, Okada M, Hara Y. Contractile characteristics of rat mesenteric artery after organ culture. J Vet Med Sci. 2010;72:1621-1627.
36. Morita T, Okada M, Hara Y, Yamawaki H. Mechanisms underlying impairment of endothlium-dependent relaxation by fetal bovine serum in organ-cultured rat mesenteric artery. Eur J Pharmacol. 2011;668:401-406.
37. Mukohda M, Morita T, Okada M, Hara Y, Yamawaki H. Long-term methylglyoxal treatment impairs smooth muscle contractility in organ-cultured rat mesenteric artery. Pharmacol Res. 2012;65:91-99.
38. Wang X, Chang T, Jiang B, Desai K, Wu L. Attenuation of hypertension development by aminoguanidine in spontaneously hypertensive rats: role of methylglyoxal. Am J Hypertens. 2007;20: 629-636. (Pubitemid 46777256)
39. Mukohda M, Morita T, Okada M, Hara Y, Yamawaki H. Long-term methylglyoxal (MGO) treatment impairs endothelium-dependent relaxation through down-regulation of endothelial nitric oxide (NO) synthase (eNOS) in organ-cultured rat mesenteric artery (Abstract of High Blood Pressure Research 2011 Scientific Sessions). Hypertension. 2011;58:e88.
40. Mukohda M, Okada M, Hara Y, Yamawaki H. Methylglyoxal accumulation in arterial walls causes vascular contractile dysfunction in SHR (Abstract of High Blood Pressure Research 2011 Scientific Sessions). Hypertension. 2011;58:e90.